Meeting InformationUNIVERSITY OF VIRGINIA
BOARD OF VISITORS EXECUTIVE SUMMARY
HEALTH AFFAIRS COMMITTEE
February 25, 2000
8:30 - 9:15 a.m., East Oval Room, The Rotunda
I. CONSENT AGENDA
A. CONFLICT OF INTEREST EXEMPTION (UPSTATE BIOTECHNOLOGY, INC.) -- Approves an exemption from the Virginia Conflict of Interests Act to allow the University of Virginia to enter into a contract with Upstate Biotechnology, Inc., for research in and commercialization of bioreagents.
B. CONFLICT OF INTEREST EXEMPTION (DIRECT GENE, INC.) -- Approves an exemption from the Virginia Conflict of Interests Act to allow the University of Virginia to enter into a contract with DirectGene, Inc., for development of gene therapies for cancer and other diseases.
II. REPORTS BY THE VICE PRESIDENT AND PROVOST FOR THE HEALTH SYSTEM
A. UNIVERSITY OF VIRGINIA MEDICAL CENTER FINANCIAL REPORT (as of January 31, 2000) -- Mr. Fitzgerald will report on the Medical Center's financial statement as of December 31, 1999, and comment on trends observed as of January 31, 2000.
B. MEDICAL CENTER COST REDUCTION -- Mr. Carter will report on the implementation of the process improvement efforts.
C. VICE PRESIDENT'S REMARKS -- Dr. Cantrell will report on significant developments impacting the Health System that have occurred since the last meeting.